Through our patented, liquid biopsy process, Circulogene delivers tumor monitoring with minimal-volumes of blood.
Noninvasive Precision Medicine
Circulogene only requires a minimal-volume of blood.
Accurate Identification of Tumor Mutations
Circulogene’s tests locate and capture cell-free DNA, identifying and quantifying any known tumor mutations for accurate reporting and monitoring.
Tumor DNA Matched with Treatment
In our personalized gene reports, we provide further information on current FDA-approved treatment options for the tumor DNA identified.
Track Responsiveness Frequently
The efficiency of Circulogene’s process empowers you and your doctor to closely monitor tumor responsiveness and adjust treatment protocols. Turnaround time is five to seven days, which is much faster than tissue biopsy results.